Table of Content

1 GABA Receptor Agonist Drug Market Overview
1.1 GABA Receptor Agonist Drug Product Scope
1.2 GABA Receptor Agonist Drug Segment by Type
1.2.1 Global GABA Receptor Agonist Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Bamaluzole
1.2.3 Phenibut
1.2.4 Baclofen
1.2.5 Gaboxadol
1.2.6 Klonopin (clonazepam)
1.2.7 Tiagbine
1.3 GABA Receptor Agonist Drug Segment by Application
1.3.1 Global GABA Receptor Agonist Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Attention Deficit Hyperactivity Disorder (ADHD)
1.3.3 Psychiatric Disorders and Depression
1.3.4 Alzheimer
1.3.5 Epilepsy and Seizure
1.3.6 Anxiety and Sleep Disorders
1.3.7 Obesity and Alcoholism
1.4 GABA Receptor Agonist Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global GABA Receptor Agonist Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global GABA Receptor Agonist Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global GABA Receptor Agonist Drug Price Trends (2016-2027)

2 GABA Receptor Agonist Drug Estimates and Forecasts by Region
2.1 Global GABA Receptor Agonist Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global GABA Receptor Agonist Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global GABA Receptor Agonist Drug Sales Market Share by Region (2016-2021)
2.2.2 Global GABA Receptor Agonist Drug Revenue Market Share by Region (2016-2021)
2.3 Global GABA Receptor Agonist Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global GABA Receptor Agonist Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global GABA Receptor Agonist Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America GABA Receptor Agonist Drug Estimates and Projections (2016-2027)
2.4.2 Europe GABA Receptor Agonist Drug Estimates and Projections (2016-2027)
2.4.3 China GABA Receptor Agonist Drug Estimates and Projections (2016-2027)
2.4.4 Japan GABA Receptor Agonist Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia GABA Receptor Agonist Drug Estimates and Projections (2016-2027)
2.4.6 India GABA Receptor Agonist Drug Estimates and Projections (2016-2027)

3 Global GABA Receptor Agonist Drug Competition Landscape by Players
3.1 Global Top GABA Receptor Agonist Drug Players by Sales (2016-2021)
3.2 Global Top GABA Receptor Agonist Drug Players by Revenue (2016-2021)
3.3 Global GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in GABA Receptor Agonist Drug as of 2020)
3.4 Global GABA Receptor Agonist Drug Average Price by Company (2016-2021)
3.5 Manufacturers GABA Receptor Agonist Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global GABA Receptor Agonist Drug Market Size by Type
4.1 Global GABA Receptor Agonist Drug Historic Market Review by Type (2016-2021)
4.1.1 Global GABA Receptor Agonist Drug Sales Market Share by Type (2016-2021)
4.1.2 Global GABA Receptor Agonist Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global GABA Receptor Agonist Drug Price by Type (2016-2021)
4.2 Global GABA Receptor Agonist Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global GABA Receptor Agonist Drug Sales Forecast by Type (2022-2027)
4.2.2 Global GABA Receptor Agonist Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global GABA Receptor Agonist Drug Price Forecast by Type (2022-2027)

5 Global GABA Receptor Agonist Drug Market Size by Application
5.1 Global GABA Receptor Agonist Drug Historic Market Review by Application (2016-2021)
5.1.1 Global GABA Receptor Agonist Drug Sales Market Share by Application (2016-2021)
5.1.2 Global GABA Receptor Agonist Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global GABA Receptor Agonist Drug Price by Application (2016-2021)
5.2 Global GABA Receptor Agonist Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global GABA Receptor Agonist Drug Sales Forecast by Application (2022-2027)
5.2.2 Global GABA Receptor Agonist Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global GABA Receptor Agonist Drug Price Forecast by Application (2022-2027)

6 North America GABA Receptor Agonist Drug Market Facts & Figures
6.1 North America GABA Receptor Agonist Drug Sales by Company
6.1.1 North America GABA Receptor Agonist Drug Sales by Company (2016-2021)
6.1.2 North America GABA Receptor Agonist Drug Revenue by Company (2016-2021)
6.2 North America GABA Receptor Agonist Drug Sales Breakdown by Type
6.2.1 North America GABA Receptor Agonist Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America GABA Receptor Agonist Drug Sales Breakdown by Type (2022-2027)
6.3 North America GABA Receptor Agonist Drug Sales Breakdown by Application
6.3.1 North America GABA Receptor Agonist Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America GABA Receptor Agonist Drug Sales Breakdown by Application (2022-2027)

7 Europe GABA Receptor Agonist Drug Market Facts & Figures
7.1 Europe GABA Receptor Agonist Drug Sales by Company
7.1.1 Europe GABA Receptor Agonist Drug Sales by Company (2016-2021)
7.1.2 Europe GABA Receptor Agonist Drug Revenue by Company (2016-2021)
7.2 Europe GABA Receptor Agonist Drug Sales Breakdown by Type
7.2.1 Europe GABA Receptor Agonist Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe GABA Receptor Agonist Drug Sales Breakdown by Type (2022-2027)
7.3 Europe GABA Receptor Agonist Drug Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)

8 China GABA Receptor Agonist Drug Market Facts & Figures
8.1 China GABA Receptor Agonist Drug Sales by Company
8.1.1 China GABA Receptor Agonist Drug Sales by Company (2016-2021)
8.1.2 China GABA Receptor Agonist Drug Revenue by Company (2016-2021)
8.2 China GABA Receptor Agonist Drug Sales Breakdown by Type
8.2.1 China GABA Receptor Agonist Drug Sales Breakdown by Type (2016-2021)
8.2.2 China GABA Receptor Agonist Drug Sales Breakdown by Type (2022-2027)
8.3 China GABA Receptor Agonist Drug Sales Breakdown by Application
8.3.1 China 160 Sales Breakdown by Application (2016-2021)
8.3.2 China 160 Sales Breakdown by Application (2022-2027)

9 Japan GABA Receptor Agonist Drug Market Facts & Figures
9.1 Japan GABA Receptor Agonist Drug Sales by Company
9.1.1 Japan GABA Receptor Agonist Drug Sales by Company (2016-2021)
9.1.2 Japan GABA Receptor Agonist Drug Revenue by Company (2016-2021)
9.2 Japan GABA Receptor Agonist Drug Sales Breakdown by Type
9.2.1 Japan GABA Receptor Agonist Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan GABA Receptor Agonist Drug Sales Breakdown by Type (2022-2027)
9.3 Japan GABA Receptor Agonist Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia GABA Receptor Agonist Drug Market Facts & Figures
10.1 Southeast Asia GABA Receptor Agonist Drug Sales by Company
10.1.1 Southeast Asia GABA Receptor Agonist Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia GABA Receptor Agonist Drug Revenue by Company (2016-2021)
10.2 Southeast Asia GABA Receptor Agonist Drug Sales Breakdown by Type
10.2.1 Southeast Asia GABA Receptor Agonist Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia GABA Receptor Agonist Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia GABA Receptor Agonist Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India GABA Receptor Agonist Drug Market Facts & Figures
11.1 India GABA Receptor Agonist Drug Sales by Company
11.1.1 India GABA Receptor Agonist Drug Sales by Company (2016-2021)
11.1.2 India GABA Receptor Agonist Drug Revenue by Company (2016-2021)
11.2 India GABA Receptor Agonist Drug Sales Breakdown by Type
11.2.1 India GABA Receptor Agonist Drug Sales Breakdown by Type (2016-2021)
11.2.2 India GABA Receptor Agonist Drug Sales Breakdown by Type (2022-2027)
11.3 India GABA Receptor Agonist Drug Sales Breakdown by Application
11.3.1 India GABA Receptor Agonist Drug Sales Breakdown by Application (2016-2021)
11.3.2 India GABA Receptor Agonist Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in GABA Receptor Agonist Drug Business
12.1 Advicenne
12.1.1 Advicenne Corporation Information
12.1.2 Advicenne Business Overview
12.1.3 Advicenne GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Advicenne GABA Receptor Agonist Drug Products Offered
12.1.5 Advicenne Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Business Overview
12.2.3 AstraZeneca GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca GABA Receptor Agonist Drug Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Athena Drug Delivery Solutions
12.3.1 Athena Drug Delivery Solutions Corporation Information
12.3.2 Athena Drug Delivery Solutions Business Overview
12.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Products Offered
12.3.5 Athena Drug Delivery Solutions Recent Development
12.4 Biocodex
12.4.1 Biocodex Corporation Information
12.4.2 Biocodex Business Overview
12.4.3 Biocodex GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Biocodex GABA Receptor Agonist Drug Products Offered
12.4.5 Biocodex Recent Development
12.5 Elan Corporation
12.5.1 Elan Corporation Corporation Information
12.5.2 Elan Corporation Business Overview
12.5.3 Elan Corporation GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Elan Corporation GABA Receptor Agonist Drug Products Offered
12.5.5 Elan Corporation Recent Development
12.6 Eli Lilly and Company
12.6.1 Eli Lilly and Company Corporation Information
12.6.2 Eli Lilly and Company Business Overview
12.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Eli Lilly and Company GABA Receptor Agonist Drug Products Offered
12.6.5 Eli Lilly and Company Recent Development
12.7 H.LundBeck, Merck and Co
12.7.1 H.LundBeck, Merck and Co Corporation Information
12.7.2 H.LundBeck, Merck and Co Business Overview
12.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Products Offered
12.7.5 H.LundBeck, Merck and Co Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Corporation Information
12.8.2 GlaxoSmithKline Business Overview
12.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 GlaxoSmithKline GABA Receptor Agonist Drug Products Offered
12.8.5 GlaxoSmithKline Recent Development
12.9 NovaDel Pharma
12.9.1 NovaDel Pharma Corporation Information
12.9.2 NovaDel Pharma Business Overview
12.9.3 NovaDel Pharma GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 NovaDel Pharma GABA Receptor Agonist Drug Products Offered
12.9.5 NovaDel Pharma Recent Development
12.10 Novartis
12.10.1 Novartis Corporation Information
12.10.2 Novartis Business Overview
12.10.3 Novartis GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis GABA Receptor Agonist Drug Products Offered
12.10.5 Novartis Recent Development
12.11 OVATION Pharmaceuticals
12.11.1 OVATION Pharmaceuticals Corporation Information
12.11.2 OVATION Pharmaceuticals Business Overview
12.11.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Products Offered
12.11.5 OVATION Pharmaceuticals Recent Development
12.12 Osmotica Pharmaceutical
12.12.1 Osmotica Pharmaceutical Corporation Information
12.12.2 Osmotica Pharmaceutical Business Overview
12.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Products Offered
12.12.5 Osmotica Pharmaceutical Recent Development
12.13 Pfizer
12.13.1 Pfizer Corporation Information
12.13.2 Pfizer Business Overview
12.13.3 Pfizer GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Pfizer GABA Receptor Agonist Drug Products Offered
12.13.5 Pfizer Recent Development
12.14 sanofi-aventis
12.14.1 sanofi-aventis Corporation Information
12.14.2 sanofi-aventis Business Overview
12.14.3 sanofi-aventis GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 sanofi-aventis GABA Receptor Agonist Drug Products Offered
12.14.5 sanofi-aventis Recent Development
12.15 VIVUS
12.15.1 VIVUS Corporation Information
12.15.2 VIVUS Business Overview
12.15.3 VIVUS GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 VIVUS GABA Receptor Agonist Drug Products Offered
12.15.5 VIVUS Recent Development
12.16 XenoPort
12.16.1 XenoPort Corporation Information
12.16.2 XenoPort Business Overview
12.16.3 XenoPort GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2016-2021)
12.16.4 XenoPort GABA Receptor Agonist Drug Products Offered
12.16.5 XenoPort Recent Development

13 GABA Receptor Agonist Drug Manufacturing Cost Analysis
13.1 GABA Receptor Agonist Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of GABA Receptor Agonist Drug
13.4 GABA Receptor Agonist Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 GABA Receptor Agonist Drug Distributors List
14.3 GABA Receptor Agonist Drug Customers

15 Market Dynamics
15.1 GABA Receptor Agonist Drug Market Trends
15.2 GABA Receptor Agonist Drug Drivers
15.3 GABA Receptor Agonist Drug Market Challenges
15.4 GABA Receptor Agonist Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global GABA Receptor Agonist Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global GABA Receptor Agonist Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global GABA Receptor Agonist Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global GABA Receptor Agonist Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global GABA Receptor Agonist Drug Sales Market Share by Region (2016-2021)
Table 6. Global GABA Receptor Agonist Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global GABA Receptor Agonist Drug Revenue Share by Region (2016-2021)
Table 8. Global GABA Receptor Agonist Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global GABA Receptor Agonist Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global GABA Receptor Agonist Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global GABA Receptor Agonist Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global GABA Receptor Agonist Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global GABA Receptor Agonist Drug Sales Share by Company (2016-2021)
Table 14. Global GABA Receptor Agonist Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global GABA Receptor Agonist Drug Revenue Share by Company (2016-2021)
Table 16. Global GABA Receptor Agonist Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GABA Receptor Agonist Drug as of 2020)
Table 17. Global GABA Receptor Agonist Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers GABA Receptor Agonist Drug Manufacturing Sites and Area Served
Table 19. Manufacturers GABA Receptor Agonist Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global GABA Receptor Agonist Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global GABA Receptor Agonist Drug Sales Share by Type (2016-2021)
Table 23. Global GABA Receptor Agonist Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global GABA Receptor Agonist Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global GABA Receptor Agonist Drug Sales Share by Type (2022-2027)
Table 26. Global GABA Receptor Agonist Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global GABA Receptor Agonist Drug Revenue Share by Type (2022-2027)
Table 28. Global GABA Receptor Agonist Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global GABA Receptor Agonist Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global GABA Receptor Agonist Drug Sales Share by Application (2016-2021)
Table 31. Global GABA Receptor Agonist Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global GABA Receptor Agonist Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global GABA Receptor Agonist Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global GABA Receptor Agonist Drug Sales Share by Application (2022-2027)
Table 35. Global GABA Receptor Agonist Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global GABA Receptor Agonist Drug Revenue Share by Application (2022-2027)
Table 37. Global GABA Receptor Agonist Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America GABA Receptor Agonist Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America GABA Receptor Agonist Drug Sales Market Share by Company (2016-2021)
Table 40. North America GABA Receptor Agonist Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America GABA Receptor Agonist Drug Revenue Market Share by Company (2016-2021)
Table 42. North America GABA Receptor Agonist Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America GABA Receptor Agonist Drug Sales Market Share by Type (2016-2021)
Table 44. North America GABA Receptor Agonist Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America GABA Receptor Agonist Drug Sales Market Share by Type (2022-2027)
Table 46. North America GABA Receptor Agonist Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America GABA Receptor Agonist Drug Sales Market Share by Application (2016-2021)
Table 48. North America GABA Receptor Agonist Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America GABA Receptor Agonist Drug Sales Market Share by Application (2022-2027)
Table 50. Europe GABA Receptor Agonist Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe GABA Receptor Agonist Drug Sales Market Share by Company (2016-2021)
Table 52. Europe GABA Receptor Agonist Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe GABA Receptor Agonist Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe GABA Receptor Agonist Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe GABA Receptor Agonist Drug Sales Market Share by Type (2016-2021)
Table 56. Europe GABA Receptor Agonist Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe GABA Receptor Agonist Drug Sales Market Share by Type (2022-2027)
Table 58. Europe GABA Receptor Agonist Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe GABA Receptor Agonist Drug Sales Market Share by Application (2016-2021)
Table 60. Europe GABA Receptor Agonist Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe GABA Receptor Agonist Drug Sales Market Share by Application (2022-2027)
Table 62. China GABA Receptor Agonist Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China GABA Receptor Agonist Drug Sales Market Share by Company (2016-2021)
Table 64. China GABA Receptor Agonist Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China GABA Receptor Agonist Drug Revenue Market Share by Company (2016-2021)
Table 66. China GABA Receptor Agonist Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China GABA Receptor Agonist Drug Sales Market Share by Type (2016-2021)
Table 68. China GABA Receptor Agonist Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China GABA Receptor Agonist Drug Sales Market Share by Type (2022-2027)
Table 70. China GABA Receptor Agonist Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China GABA Receptor Agonist Drug Sales Market Share by Application (2016-2021)
Table 72. China GABA Receptor Agonist Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China GABA Receptor Agonist Drug Sales Market Share by Application (2022-2027)
Table 74. Japan GABA Receptor Agonist Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan GABA Receptor Agonist Drug Sales Market Share by Company (2016-2021)
Table 76. Japan GABA Receptor Agonist Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan GABA Receptor Agonist Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan GABA Receptor Agonist Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan GABA Receptor Agonist Drug Sales Market Share by Type (2016-2021)
Table 80. Japan GABA Receptor Agonist Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan GABA Receptor Agonist Drug Sales Market Share by Type (2022-2027)
Table 82. Japan GABA Receptor Agonist Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan GABA Receptor Agonist Drug Sales Market Share by Application (2016-2021)
Table 84. Japan GABA Receptor Agonist Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan GABA Receptor Agonist Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia GABA Receptor Agonist Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia GABA Receptor Agonist Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia GABA Receptor Agonist Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia GABA Receptor Agonist Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia GABA Receptor Agonist Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia GABA Receptor Agonist Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia GABA Receptor Agonist Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia GABA Receptor Agonist Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia GABA Receptor Agonist Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia GABA Receptor Agonist Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia GABA Receptor Agonist Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia GABA Receptor Agonist Drug Sales Market Share by Application (2022-2027)
Table 98. India GABA Receptor Agonist Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India GABA Receptor Agonist Drug Sales Market Share by Company (2016-2021)
Table 100. India GABA Receptor Agonist Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India GABA Receptor Agonist Drug Revenue Market Share by Company (2016-2021)
Table 102. India GABA Receptor Agonist Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India GABA Receptor Agonist Drug Sales Market Share by Type (2016-2021)
Table 104. India GABA Receptor Agonist Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India GABA Receptor Agonist Drug Sales Market Share by Type (2022-2027)
Table 106. India GABA Receptor Agonist Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India GABA Receptor Agonist Drug Sales Market Share by Application (2016-2021)
Table 108. India GABA Receptor Agonist Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India GABA Receptor Agonist Drug Sales Market Share by Application (2022-2027)
Table 110. Advicenne Corporation Information
Table 111. Advicenne Description and Business Overview
Table 112. Advicenne GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Advicenne GABA Receptor Agonist Drug Product
Table 114. Advicenne Recent Development
Table 115. AstraZeneca Corporation Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. AstraZeneca GABA Receptor Agonist Drug Product
Table 119. AstraZeneca Recent Development
Table 120. Athena Drug Delivery Solutions Corporation Information
Table 121. Athena Drug Delivery Solutions Description and Business Overview
Table 122. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product
Table 124. Athena Drug Delivery Solutions Recent Development
Table 125. Biocodex Corporation Information
Table 126. Biocodex Description and Business Overview
Table 127. Biocodex GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Biocodex GABA Receptor Agonist Drug Product
Table 129. Biocodex Recent Development
Table 130. Elan Corporation Corporation Information
Table 131. Elan Corporation Description and Business Overview
Table 132. Elan Corporation GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Elan Corporation GABA Receptor Agonist Drug Product
Table 134. Elan Corporation Recent Development
Table 135. Eli Lilly and Company Corporation Information
Table 136. Eli Lilly and Company Description and Business Overview
Table 137. Eli Lilly and Company GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Eli Lilly and Company GABA Receptor Agonist Drug Product
Table 139. Eli Lilly and Company Recent Development
Table 140. H.LundBeck, Merck and Co Corporation Information
Table 141. H.LundBeck, Merck and Co Description and Business Overview
Table 142. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product
Table 144. H.LundBeck, Merck and Co Recent Development
Table 145. GlaxoSmithKline Corporation Information
Table 146. GlaxoSmithKline GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. GlaxoSmithKline Description and Business Overview
Table 148. GlaxoSmithKline GABA Receptor Agonist Drug Product
Table 149. GlaxoSmithKline Recent Development
Table 150. NovaDel Pharma Corporation Information
Table 151. NovaDel Pharma GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. NovaDel Pharma Description and Business Overview
Table 153. NovaDel Pharma GABA Receptor Agonist Drug Product
Table 154. NovaDel Pharma Recent Development
Table 155. Novartis Corporation Information
Table 156. Novartis Description and Business Overview
Table 157. Novartis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Novartis GABA Receptor Agonist Drug Product
Table 159. Novartis Recent Development
Table 160. OVATION Pharmaceuticals Corporation Information
Table 161. OVATION Pharmaceuticals Description and Business Overview
Table 162. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product
Table 164. OVATION Pharmaceuticals Recent Development
Table 165. Osmotica Pharmaceutical Corporation Information
Table 166. Osmotica Pharmaceutical Description and Business Overview
Table 167. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product
Table 169. Osmotica Pharmaceutical Recent Development
Table 170. Pfizer Corporation Information
Table 171. Pfizer Description and Business Overview
Table 172. Pfizer GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Pfizer GABA Receptor Agonist Drug Product
Table 174. Pfizer Recent Development
Table 175. sanofi-aventis Corporation Information
Table 176. sanofi-aventis Description and Business Overview
Table 177. sanofi-aventis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. sanofi-aventis GABA Receptor Agonist Drug Product
Table 179. sanofi-aventis Recent Development
Table 180. VIVUS Corporation Information
Table 181. VIVUS Description and Business Overview
Table 182. VIVUS GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. VIVUS GABA Receptor Agonist Drug Product
Table 184. VIVUS Recent Development
Table 185. XenoPort Corporation Information
Table 186. XenoPort Description and Business Overview
Table 187. XenoPort GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. XenoPort GABA Receptor Agonist Drug Product
Table 189. XenoPort Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. GABA Receptor Agonist Drug Distributors List
Table 193. GABA Receptor Agonist Drug Customers List
Table 194. GABA Receptor Agonist Drug Market Trends
Table 195. GABA Receptor Agonist Drug Market Drivers
Table 196. GABA Receptor Agonist Drug Market Challenges
Table 197. GABA Receptor Agonist Drug Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. GABA Receptor Agonist Drug Product Picture
Figure 2. Global GABA Receptor Agonist Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Bamaluzole Product Picture
Figure 4. Phenibut Product Picture
Figure 5. Baclofen Product Picture
Figure 6. Gaboxadol Product Picture
Figure 7. Klonopin (clonazepam) Product Picture
Figure 8. Tiagbine Product Picture
Figure 9. Global GABA Receptor Agonist Drug Sales Market Share by Application in 2021 & 2027
Figure 10. Attention Deficit Hyperactivity Disorder (ADHD) Examples
Figure 11. Psychiatric Disorders and Depression Examples
Figure 12. Alzheimer Examples
Figure 13. Epilepsy and Seizure Examples
Figure 14. Anxiety and Sleep Disorders Examples
Figure 15. Obesity and Alcoholism Examples
Figure 16. Global GABA Receptor Agonist Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global GABA Receptor Agonist Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 18. Global GABA Receptor Agonist Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 19. Global GABA Receptor Agonist Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 20. Global GABA Receptor Agonist Drug Revenue Market Share by Region: 2016 VS 2021
Figure 21. Global GABA Receptor Agonist Drug Revenue Market Share by Region: 2021 VS 2027
Figure 22. North America GABA Receptor Agonist Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. North America GABA Receptor Agonist Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 24. Europe GABA Receptor Agonist Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Europe GABA Receptor Agonist Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. China GABA Receptor Agonist Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. China GABA Receptor Agonist Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 28. Japan GABA Receptor Agonist Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Japan GABA Receptor Agonist Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Southeast Asia GABA Receptor Agonist Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. Southeast Asia GABA Receptor Agonist Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 32. India GABA Receptor Agonist Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 33. India GABA Receptor Agonist Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 34. Global 5 Largest GABA Receptor Agonist Drug Players Market Share by Revenue in GABA Receptor Agonist Drug: 2016 & 2020
Figure 35. GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 36. Global GABA Receptor Agonist Drug Revenue Share by Type (2016-2021)
Figure 37. Global GABA Receptor Agonist Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 38. Global GABA Receptor Agonist Drug Revenue Share by Application (2016-2021)
Figure 39. Global GABA Receptor Agonist Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America GABA Receptor Agonist Drug Sales Market Share by Type in 2020
Figure 41. North America GABA Receptor Agonist Drug Sales Market Share by Application in 2020
Figure 42. Europe GABA Receptor Agonist Drug Sales Market Share by Type in 2020
Figure 43. Europe GABA Receptor Agonist Drug Sales Market Share by Application in 2020
Figure 44. China GABA Receptor Agonist Drug Sales Market Share by Type in 2020
Figure 45. China GABA Receptor Agonist Drug Sales Market Share by Application in 2020
Figure 46. Japan GABA Receptor Agonist Drug Sales Market Share by Type in 2020
Figure 47. Japan GABA Receptor Agonist Drug Sales Market Share by Application in 2020
Figure 48. Southeast Asia GABA Receptor Agonist Drug Sales Market Share by Type in 2020
Figure 49. Southeast Asia GABA Receptor Agonist Drug Sales Market Share by Application in 2020
Figure 50. India GABA Receptor Agonist Drug Sales Market Share by Type in 2020
Figure 51. India GABA Receptor Agonist Drug Sales Market Share by Application in 2020
Figure 52. Key Raw Materials Price Trend
Figure 53. Manufacturing Cost Structure of GABA Receptor Agonist Drug
Figure 54. Manufacturing Process Analysis of GABA Receptor Agonist Drug
Figure 55. GABA Receptor Agonist Drug Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed